Try our beta test site
429 studies found for:    Open Studies | "Schizophrenia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Trial of DMXB-A in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: 3-2,4 dimethoxybenzylidene 75 or 150 mg bid;   Drug: Placebo
2 Not yet recruiting The Optimal Treatment for Treatment-resistant Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Risperidone with Clozapine;   Drug: Aripiprazole with Clozapine;   Drug: sodium valproate with Clozapine;   Device: modified electroconvulsive therapy(MECT) with Clozapine;   Device: Magnetic seizure therapy(MST) with Clozapine
3 Not yet recruiting Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Levetiracetam;   Drug: Placebo
4 Not yet recruiting Evaluation Study of New Compounds With Potential Use in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: URB597;   Drug: intranasal Insulin;   Drug: Cannabidiol CR
5 Recruiting An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: SEP-363856
6 Recruiting Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry
Condition: Schizophrenia
Intervention: Other: insight variation measure
7 Recruiting A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo - Cap
8 Recruiting Schizophrenia TreAtment With electRic Transcranial Stimulation
Condition: Schizophrenia
Intervention: Device: Transcranial Direct Current Stimulation
9 Not yet recruiting A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia
Condition: Schizophrenia
Interventions: Dietary Supplement: sulforaphane;   Other: placebo
10 Recruiting Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive
Condition: Schizophrenia
Interventions: Other: Gluten Free Flour;   Other: Wheat Flour
11 Not yet recruiting Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients.
Condition: Schizophrenia
Intervention: Device: Repetitive Transcranial Magnetic Stimulation
12 Recruiting A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ASP4345;   Drug: Matching Placebo
13 Recruiting Aerobic Exercise for Cognition in Schizophrenia
Condition: Schizophrenia
Interventions: Behavioral: Aerobic Exercise;   Behavioral: Balance and Stretching
14 Recruiting Motivation and Executive Control in Schizophrenia
Condition: Schizophrenia
Intervention: Other: realization of computerized exercises
15 Recruiting Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
Condition: Chronic Schizophrenia
Interventions: Drug: Curcumin;   Drug: placebo
16 Recruiting Tryptophan MRI in People With Schizophrenia and Healthy Controls
Condition: Schizophrenia
Interventions: Drug: Tryptophan;   Drug: Placebo
17 Recruiting Effects of Eszopiclone on Sleep and Memory in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: eszopiclone;   Drug: placebo
18 Recruiting Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AVP-786;   Drug: Placebo
19 Recruiting Deep Brain Stimulation in Treatment Resistant Schizophrenia
Condition: Refractory Schizophrenia
Interventions: Device: On-Stimulation;   Device: Off-Stimulation
20 Recruiting A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation
Condition: Schizophrenia
Intervention: Drug: Paliperidone palmitate 3 month formulation (PP3M)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.